RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR

NCT02255422 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

MItochondrial Myopathies

Interventions

DRUG: Omaveloxolone capsules, 2.5 mg
DRUG: omaveloxolone capsules, 5 mg
DRUG: omaveloxolone capsules, 10 mg
DRUG: Placebo capsules
DRUG: omaveloxolone capsules, 20 mg
DRUG: omaveloxolone capsules, 40 mg
DRUG: omaveloxolone capsules, 80 mg
DRUG: omaveloxolone capsules, 160 mg

Sponsor

Biogen

Collaborators

[object Object]